126 related articles for article (PubMed ID: 7830098)
1. Fluconazole, itraconazole and ketoconazole in vitro activity against Candida spp.
Arévalo MP; Arias A; Andreu A; Rodríguez C; Sierra A
J Chemother; 1994 Aug; 6(4):226-9. PubMed ID: 7830098
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents.
Arias A; Arévalo MP; Andreu A; Rodríguez C; Sierra A
Mycoses; 1994; 37(7-8):285-9. PubMed ID: 7739661
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Martín E; Parras P; Lozano MC
Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
Nguyen MH; Yu CY
J Antimicrob Chemother; 1998 Aug; 42(2):253-6. PubMed ID: 9738846
[TBL] [Abstract][Full Text] [Related]
5. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
Metzger S; Hofmann H
Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
Skrodeniene E; Dambrauskiene A; Vitkauskiene A
Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
Wardle HM; Law D; Moore CB; Mason C; Denning DW
Antimicrob Agents Chemother; 1995 Apr; 39(4):868-71. PubMed ID: 7785986
[TBL] [Abstract][Full Text] [Related]
8. Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species.
Johnson EM; Davey KG; Szekely A; Warnock DW
J Antimicrob Chemother; 1995 Nov; 36(5):787-93. PubMed ID: 8626259
[TBL] [Abstract][Full Text] [Related]
9. Fluconazole and itraconazole susceptibilities of Candida spp. isolated from oropharyngeal specimens and blood cultures of paediatric haematology/oncology patients.
Kennedy HF; Shankland GS; Bagg J; Chalmers EA; Gibson BE; Williams CL
Mycoses; 2006 Nov; 49(6):457-62. PubMed ID: 17022761
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of several species of Candida and Torulopsis to fluconazole and ketoconazole.
Mallié M; Montès B; Reynes J; Bastide JM
Drugs Exp Clin Res; 1990; 16(10):509-13. PubMed ID: 2100733
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
Arikan S; Sancak B; Hascelik G
Med Mycol; 2005 Mar; 43(2):171-8. PubMed ID: 15832560
[TBL] [Abstract][Full Text] [Related]
13. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
14. Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Figueiredo VT; de Assis Santos D; Resende MA; Hamdan JS
Mycopathologia; 2007 Jul; 164(1):27-33. PubMed ID: 17551848
[TBL] [Abstract][Full Text] [Related]
15. [Comparative sensitivity of yeasts to ketoconazole, itraconazole and fluconazole using a liquid medium standardized micromethod].
Guinet R; Marlier H
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):575-8. PubMed ID: 2166937
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.
Sojakova M; Liptajova D; Borovsky M; Subik J
Mycopathologia; 2004 Feb; 157(2):163-9. PubMed ID: 15119851
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
Barchiesi F; Tortorano AM; Di Francesco LF; Cogliati M; Scalise G; Viviani MA
J Antimicrob Chemother; 1999 Feb; 43(2):295-9. PubMed ID: 11252339
[TBL] [Abstract][Full Text] [Related]
18. High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients.
Darma S; Ambara A; Aman AT; Annisa L; Nurrokhman ; Nuryastuti T; Wibawa T
PLoS One; 2020; 15(11):e0242542. PubMed ID: 33212470
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of Candida spp. to fluconazole, itraconazole and voriconazole and the correlation between triazoles susceptibility: Results from a five-year study.
Lei J; Xu J; Wang T
J Mycol Med; 2018 Jun; 28(2):310-313. PubMed ID: 29685520
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.
Cuenca-Estrella M; Mellado E; Díaz-Guerra TM; Monzón A; Rodríguez-Tudela JL
J Antimicrob Chemother; 2000 Sep; 46(3):475-7. PubMed ID: 10980178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
